Complete response associated with immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysis of nine randomized controlled trials

PURPOSE: The purposes of this study were to investigate whether the use of immune checkpoint inhibitors (ICIs) in advanced non-small-cell lung cancer (NSCLC) would increase the possibility of archiving complete response (CR) and assess the surrogate end points for overall survival (OS). METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, He, Qi, Yu, Xiu, Khan, Khalid, Weng, Xuanwen, Guan, Minjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388963/
https://www.ncbi.nlm.nih.gov/pubmed/30863172
http://dx.doi.org/10.2147/CMAR.S188551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388963/
https://www.ncbi.nlm.nih.gov/pubmed/30863172
http://dx.doi.org/10.2147/CMAR.S188551

Ejemplares similares